Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-02

Clinical Trial Update: Non-interventional Study to Evaluate Long Term Safety, Prescription Management Patterns of Esmya in a Long Term Setting

View source ↗

Summary

A completed non-interventional study assessing long-term safety and prescription management patterns of Esmya (ulipristal acetate) in women with uterine fibroid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esmya (ulipristal acetate)

Snippet

Sponsor: PregLem SA | Conditions: Uterine Fibroids | Status: COMPLETED